Risk assessment of over-the-counter cannabinoid-based cosmetics: Legal and regulatory issues governing the safety of cannabinoid-based cosmetics in the UAE
| ATC code R: Respiratory system |
|---|
|
| Other ATC codes |
ATC code R06 Antihistamines for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup R06 is part of the anatomical group R Respiratory system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR06.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
R06A Antihistamines for systemic use
R06AA Aminoalkyl ethers
- R06AA01 Bromazine
- R06AA02 Diphenhydramine
- R06AA04 Clemastine
- R06AA06 Chlorphenoxamine
- R06AA07 Diphenylpyraline
- R06AA08 Carbinoxamine
- R06AA09 Doxylamine
- R06AA10 Trimethobenzamide
- R06AA11 Dimenhydrinate
- R06AA52 Diphenhydramine, combinations
- R06AA54 Clemastine, combinations
- R06AA56 Chlorphenoxamine, combinations
- R06AA57 Diphenylpyraline, combinations
- R06AA59 Doxylamine, combinations
- R06AA61 Dimenhydrinate, combinations
R06AB Substituted alkylamines
- R06AB01 Brompheniramine
- R06AB02 Dexchlorpheniramine
- R06AB03 Dimetindene
- R06AB04 Chlorphenamine
- R06AB05 Pheniramine
- R06AB06 Dexbrompheniramine
- R06AB07 Talastine
- R06AB51 Brompheniramine, combinations
- R06AB52 Dexchlorpheniramine, combinations
- R06AB54 Chlorphenamine, combinations
- R06AB56 Dexbrompheniramine, combinations
R06AC Substituted ethylene diamines
- R06AC01 Mepyramine
- R06AC02 Histapyrrodine
- R06AC03 Chloropyramine
- R06AC04 Tripelennamine
- R06AC05 Methapyrilene
- R06AC06 Thonzylamine
- R06AC52 Histapyrrodine, combinations
- R06AC53 Chloropyramine, combinations
R06AD Phenothiazine derivatives
- R06AD01 Alimemazine
- R06AD02 Promethazine
- R06AD03 Thiethylperazine
- R06AD04 Methdilazine
- R06AD05 Hydroxyethylpromethazine
- R06AD06 Thiazinam
- R06AD07 Mequitazine
- R06AD08 Oxomemazine
- R06AD09 Isothipendyl
- R06AD52 Promethazine, combinations
- R06AD55 Hydroxyethylpromethazine, combinations
R06AE Piperazine derivatives
- R06AE01 Buclizine
- R06AE03 Cyclizine
- R06AE04 Chlorcyclizine
- R06AE05 Meclozine
- R06AE06 Oxatomide
- R06AE07 Cetirizine
- R06AE09 Levocetirizine
- R06AE51 Buclizine, combinations
- R06AE53 Cyclizine, combinations
- R06AE55 Meclozine, combinations
R06AK Combinations of antihistamines
- Empty group
R06AX Other antihistamines for systemic use
- R06AX01 Bamipine
- R06AX02 Cyproheptadine
- R06AX03 Thenalidine
- R06AX04 Phenindamine
- R06AX05 Antazoline
- R06AX07 Triprolidine
- R06AX08 Pyrrobutamine
- R06AX09 Azatadine
- R06AX11 Astemizole
- R06AX12 Terfenadine
- R06AX13 Loratadine
- R06AX15 Mebhydrolin
- R06AX16 Deptropine
- R06AX17 Ketotifen
- R06AX18 Acrivastine
- R06AX19 Azelastine
- R06AX21 Tritoqualine
- R06AX22 Ebastine
- R06AX23 Pimethixene
- R06AX24 Epinastine
- R06AX25 Mizolastine
- R06AX26 Fexofenadine
- R06AX27 Desloratadine
- R06AX28 Rupatadine
- R06AX29 Bilastine
- R06AX31 Quifenadine
- R06AX32 Sequifenadine
- R06AX53 Thenalidine, combinations
- R06AX58 Pyrrobutamine, combinations
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code R06". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QR06". WHO Collaborating Centre for Drug Statistics Methodology.
